BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12780832)

  • 1. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.
    Heyns CF; Mathee S; Isaacs A; Kharwa A; De Beer PM; Pretorius MA
    BJU Int; 2003 Jun; 91(9):785-8. PubMed ID: 12780832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of prostate cancer in the Western Cape.
    Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
    S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa.
    Maphayi MR; Cassim N; Bello B; George JA
    Pan Afr Med J; 2020; 35():61. PubMed ID: 32537065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
    Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
    Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
    Fowler JE; Bigler SA; Farabaugh PB
    Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?
    Durkan GC; Greene DR
    BJU Int; 1999 Jan; 83(1):34-8. PubMed ID: 10233448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
    Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
    Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer screening parameters in a high-risk African-Caribbean population.
    Bunker CH; Patrick AL; Miljkovic-Gacic I; Konety BR; Belle A; Richard JR; Dhir R
    Urology; 2004 Apr; 63(4):737-41. PubMed ID: 15072891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients.
    Porter CR; Kim J
    Urology; 2004 Jan; 63(1):90-4. PubMed ID: 14751356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
    Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
    J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Littrup PJ; Kane RA; Mettlin CJ; Murphy GP; Lee F; Toi A; Badalament R; Babaian R
    Cancer; 1994 Dec; 74(12):3146-58. PubMed ID: 7526969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination.
    Leewansangtong S; Tantiwong A; Ratanarapee S; Nualyong C; Soontrapa S
    J Med Assoc Thai; 2000 Dec; 83(12):1519-24. PubMed ID: 11253893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR; Evans WP; Borden JD; Castellanos RD
    Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy.
    Ito K; Ichinose Y; Kubota Y; Imai K; Yamanaka H
    Int J Urol; 1997 Sep; 4(5):474-9. PubMed ID: 9354949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
    Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
    Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
    Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
    J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
    Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
    Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in operating characteristics of prostate cancer screening tests.
    Smith DS; Bullock AD; Catalona WJ
    J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.